BANK OF MONTREAL /CAN/ - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 27 filers reported holding TRINITY BIOTECH PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q4 2019$3,000
-25.0%
3,2090.0%0.00%
Q3 2019$4,000
-20.0%
3,2090.0%0.00%
Q2 2019$5,000
-44.4%
3,2090.0%0.00%
Q1 2019$9,000
+28.6%
3,2090.0%0.00%
Q4 2018$7,000
-46.2%
3,2090.0%0.00%
Q3 2018$13,000
-18.8%
3,2090.0%0.00%
Q2 2018$16,000
-5.9%
3,2090.0%0.00%
Q1 2018$17,000
+6.2%
3,2090.0%0.00%
Q4 2017$16,000
-11.1%
3,2090.0%0.00%
Q3 2017$18,000
-5.3%
3,2090.0%0.00%
Q2 2017$19,000
-34.5%
3,209
-33.9%
0.00%
Q1 2017$29,000
-96.3%
4,852
-95.9%
0.00%
-100.0%
Q4 2016$787,000
-88.2%
117,616
-76.7%
0.00%
-85.7%
Q3 2016$6,660,000
-19.2%
503,782
-30.7%
0.01%
-22.2%
Q2 2016$8,242,000
-30.3%
726,778
-28.4%
0.01%
-30.8%
Q1 2016$11,830,000
-9.3%
1,014,616
-8.5%
0.01%
-18.8%
Q4 2015$13,045,000
+144844.4%
1,109,258
+282874.0%
0.02%
Q3 2013$9,0003920.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2019
NameSharesValueWeighting ↓
ACK Asset Management 928,000$10,616,0004.44%
GOLDMAN CAPITAL MANAGEMENT INC 350,961$4,015,0002.86%
Paradice Investment Management LLC 992,235$11,351,0002.07%
Centaur Capital 77,500$887,0001.33%
Adirondack Funds 302,305$3,458,0001.33%
Adirondack Research & Management Inc. 302,305$3,458,0001.33%
RK Capital 565,472$6,469,0001.18%
Lyon Street Capital, LLC 140,943$1,612,0001.17%
Benchmark Capital Advisors 89,941$1,029,0000.84%
KEANE CAPITAL MANAGEMENT INC 55,045$630,0000.83%
View complete list of TRINITY BIOTECH PLC shareholders